Results of Progressive Resistance Training in Older Type 2 Diabetic Patients With Sarcopenia
A legfontosabb adatok
- Ki végzi
- National Geriatric Hospital
- Hol
- Hanoi (Vietnám)A helyszín megnézése
- Azonosító
- Állapot
- Befejeződött
- Résztvevők
- 70 fő vett részt
- Kezdés
- 2024. máj. 1.
- Befejezés
- 2025. dec. 31.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport nem kap vizsgálati kezelést, összehasonlításként.
- A vizsgált kezelések
- Progressive Resistance Training
- A regiszteradat frissítve
- 2026. november 12.
Ki vehet részt
- Életkor
- 60 év – 80 év
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 11 feltétel megnézéseKevesebb
Ki vehet részt
- Type 2 diabetic patients diagnosed using American Diabetes Association 2022 criteria
- HbA1c ≥ 7.0 and ≤ 8.5%
- Sarcopenia diagnosed using criteria from the Asian Working Group for Sarcopenia 2019
- Age ≥ 60 and ≤ 80
Ki nem vehet részt
- Patients are in the acute phase of musculoskeletal disorders: acute gout, progressing rheumatoid arthritis, acute joint pain due to joint degeneration, sciatic pain, and infectious arthritis
- Patients suffer from conditions significantly affecting cognition and mobility: sequelae of stroke (with weakness, limb paralysis), muscular weakness, limb disabilities, severe heart failure, severe cognitive decline, and psychiatric disorders
- Patients have been bedridden due to illness for more than 1 month within the past 3 months up to the recruitment time
- Patients with cardiovascular diseases: chest pain, uncontrolled blood pressure ≥160/100 mmHg, untreated cardiac arrhythmia, a history of congestive heart failure, severe valvular heart disease, myocarditis or pericarditis, and hypertrophic cardiomyopathy
- Renal failure with estimated glomerular function rate (Modification of Diet in Renal Disease equation) < 60 ml/min/m3 or serum creatinine ≥ 130 µmol/l
- On treatment with Sodium-glucose cotransporter 2 inhibitors (SGLT2i) or GLP-1 receptor agonists
- Acute diabetic complications
Helyszínek itt: Vietnám
- National Geriatric HospitalHanoi, Vietnám
A vizsgálatról
Mit akar kideríteni a vizsgálat
A randomized controlled clinical trial that will test how progressive resistance training will impact outcomes of sarcopenia in older patients with type 2 diabetes who have been diagnosed as sarcopenia. The intervention will be 12 weeks in duration with approximately 24 sessions of resistance exercises. Outcome measures will be collected at baseline, 4, 8 weeks and 12 weeks.
A vizsgálat 2 csoportja
- Intervention groupA vizsgált kezelés
The intervention group receives supervised resistance training instructions and baseline treatment for sarcopenia and diabetes: * Resistance training with elastic bands aims to increase muscle strength and muscle mass of the upper and lower limbs. Training duration 12 weeks, frequency 2 times/week, intensity gradually increases. * Baseline treatment for diabetes and sarcopenia: Recommendations according to American Diabetes Association guidelines which include instructions to follow the diet and exercises as recommended for older type 2 diabetic patients and baseline treatment for sarcopenia (education about sarcopenia and treatment measures such as diet and exercise) and provide basic information on resistance training.
Kezelés: Progressive Resistance Training
- Control groupNincs vizsgálati kezelés, összehasonlításként
The control group receives the baseline treatment for diabetes and sarcopenia: \- Recommendations according to American Diabetes Association guidelines which include instructions to follow the diet and exercises as recommended for older type 2 diabetic patients and baseline treatment for sarcopenia (education about sarcopenia and treatment measures such as diet and exercise) and provide basic information on resistance training.
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Evaluating Resistance Training for Sarcopenia in Older Patients With Type 2 Diabetes: Treatment Outcomes
- A regiszteradat frissítve
- 2026. november 12.